From the *Pediatric Infectious Diseases Unit, Department of Pediatrics, Hospital Universitario 12 de Octubre, Universidad Complutense de Madrid, Madrid, Spain
†Pediatric Research and Clinical Trials Unit (UPIC), Instituto de Investigación Hospital 12 de Octubre (imas12), Madrid, Spain
‡Pediatrics, Infectious and Tropical Diseases Department, Hospital Universitario La Paz, Instituto Investigación Hospital La Paz (IDIPaz), Madrid, Spain
§Red de Investigación Translacional en Infectología Pediátrica, Madrid, Spain
¶Malalties Infeccioses i Resposta Inflamatòria Sistèmica en Pediatria, Unitat d’Infeccions, Servei de Pediatria, Institut de Recerca Pediàtrica Hospital Sant Joan de Déu, Barcelona, Spain
‖Departament de Pediatria, Universitat de Barcelona, Barcelona, Spain
**Centro de Investigación Biomédica en Red de Epidemiología y Salud Pública, Madrid, Spain
††Pediatric Infectious Diseases and Immunodeficiencies Unit, Department of Pediatrics, Hospital Universitari Vall d’Hebron, Barcelona, Spain.
‡‡‡Members of Spanish Registry of Infants with Congenital Cytomegalovirus Infection (REDICCMV) are listed in the Acknowledgments.
Accepted for publication March 14, 2022
S.V. is funded by the Spanish Ministry of Science and Innovation—Instituto de Salud Carlos III and Fondos FEDER (Contrato Río Hortega CM20/00173). This work was funded by projects PI 16/00807, PI19/0009, and PI 19/01333, from the Instituto de Salud Carlos III (Ministry of Economy, Industry, and Competitiveness) and cofounded by the European Regional Development Fund. D.B.-G. was supported by the Spanish Ministry of Science and Innovation—Instituto de Salud Carlos III and Fondos FEDER by “Contratos para la intensificación de la actividad investigadora en el Sistema Nacional de Salud, 2020 (INT20/00086).” A.N.-J. was supported by “Subvencions per a la Intensificació de Facultatius Especialistes” (Departament de Salut de la Generalitat de Catalunya, Programa PERIS 2016-2020) [SLT008/18/00193].
D.B.-G. has received fees from MSD as speaker in educational activities. The remaining authors have no conflicts of interest to disclose.
Address for correspondence: Serena Villaverde, MD, Pediatric Infectious Disease Unit, Pediatric Research and Clinical Trials Unit (UPIC), Department of Pediatrics, Hospital Universitario 12 de Octubre, Universidad Complutense de Madrid, Av. de Córdoba, s/n, 28041 Madrid, Spain. E-mail: [email protected].